PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bfgpLink to Publisher's site
 
Brief Funct Genomic Proteomic. 2008 November; 7(6): 460–464.
Published online 2008 December 23. doi:  10.1093/bfgp/eln043
PMCID: PMC2722258

Emerging gene knockout technology in zebrafish: zinc-finger nucleases

Abstract

One advantage of the zebrafish model system is the ability to use forward genetics to reveal critical gene functions by their mutant phenotype. Reverse genetic tools are available, although it is more challenging and time-consuming to identify mutations in specific genes of interest and virtually impossible to induce mutations in a targeted manner. Two recent papers have shown that locus-specific zinc-finger nucleases (ZFNs) can be used to create mutations in investigator-specified loci at high frequency, generating considerable enthusiasm that the technology may be generally applicable to many zebrafish genes. The rate-limiting step in ZFN application is typically the zinc-finger protein (ZFP) design phase, partly because ZFPs that bind to intended target sequences in naked DNA may not recognize the target within chromatin, or may recognize cryptic sites. Importantly, both papers also provide new tools to validate or pre-select ZFNs that work well in vivo and thus greatly facilitate the identification of active ZFNs. Finally, work in other model systems and in cultured cells show that ZFNs can facilitate homology-directed repair, raising the exciting possibility that ZFNs may facilitate homologous recombination in zebrafish, allowing site-specific modification of endogenous genes via a method that does not require embryonic stem cell technology.

Keywords: gene targeting, targeted mutagenesis, zebrafish, zinc-finger nuclease, non-homologous end joining, double-strand break repair

Forward and reverse genetic strategies have been critical to our understanding of gene function. That said, targeted genome manipulation in vertebrates has been largely restricted to the mouse, due to the availability of mouse embryonic stem cell lines that can be manipulated in culture and reintroduced into mouse blastocysts [1]. However, zinc-finger nucleases (ZFNs) have been shown to be useful tools for genome manipulation in several non-mouse models and have been used successfully to modify the genomes of plants, invertebrates and cultured cell lines [2–7]. ZFNs are a fusion between the cleavage domain of the FokI restriction enzyme and three or more zinc-finger motifs designed to recognize a specific DNA target sequence. FokI is active only as a dimer, thus when two ZFNs bind DNA with appropriate orientation and spacing, the heterodimeric complex creates a double-strand break (DSB) in the DNA [8, 9]. In eukaryotes, DSB repair pathways include non-homologous end-joining (NHEJ) and homology-directed repair [10]. NHEJ, the direct ligation of two DNA ends, can be mutagenic, creating small insertions and deletions at the site of the DSB break [10]. This review focuses on two recent studies that demonstrate that ZFNs can be effectively used to stimulate NHEJ-mediated repair of targeted DSBs and thus generate gene-specific mutations in zebrafish somatic cells and germ line [11, 12]. For a more general and detailed description of ZFN technology, the reader is directed to recent reviews [13–15].

Using ZFNs to create DSBs in specific zebrafish genes, two groups disrupted three ‘proof-of-principle’ loci that give well-characterized phenotypes when mutated: mutants in kdrl (kinase insert domain receptor like; also known as flk1, kdra, and vegr2 [16]) have specific vasculature defects [17], no tail (ntl) mutant embryos lack a notochord and tail [18, 19] and golden (gol)/slc24a5 mutants lack embryonic melanosomal pigmentation [20, 21]. A schematic of the ZFN recognition sites within the kdrl and ntl genes and the ZFNs engineered to bind them are shown in Figure 1. Although differences in ZFN constructs and methodology distinguish the two studies, the basic experimental design used by both groups was similar and straightforward: mRNAs encoding ZFNs were injected into one-cell zebrafish embryos that were subsequently screened for specific mutations at the intended target locus (Figure 2). To detect somatically induced mutations, ZFN-injected founders were screened 1–2 days post-injection, either phenotypically (after ZFN mRNA injection into heterozygous carriers) or molecularly (by direct sequencing of the ZFN-targeted interval, by screening for loss of a restriction site that lies within the ZFN spacer region, and/or by assaying for cleavage by a mismatch-sensitive endonuclease). The observed mutations were typically small insertions and deletions and characteristic of DSB repair by NHEJ [11, 12].

Figure 1:
ZFN proteins and their recognition sites within the zebrafish kdrl and ntl genes. Chimeric ZFNs are composed of individual zinc-finger modules (light grey circles) fused to obligate heterodimer forms of the FokI endonuclease cleavage domain (jagged boxes). ...
Figure 2:
Experimental strategy for ZFN-induced mutagenesis within the zebrafish genome. Pairs of ZFN-encoding mRNAs are injected into zebrafish embryos at the one-cell stage. Injected embryos are scored 24–48 h later for mutations at the intended ZFN cleavage ...

In order for ZFNs to be a viable reverse genetic strategy in zebrafish, it was essential to show that ZFN-induced mutations can be effectively transmitted through the germ line. Importantly, both studies show that ZFN mRNA-injected zebrafish embryos raised to sexual maturity transmit ZFN-induced alleles to their progeny at high frequency [11, 12]. Both groups report strikingly similar results: 30% (6/20) of kdrl-targeting ZFN mRNA-injected animals transmit new kdrl alleles to their progeny at frequencies ranging from ~8% to 50% [12], and over 60% (11/18) of ntl-targeting ZFN mRNA-injected animals transmit new ntl alleles at frequencies ranging from ~1% to 50% [11]. The fact that some ZFN-injected founders transmit ZFN-induced alleles at the same frequency as a heterozygous carrier demonstrates that mutagenic events can occur very early in development. The high percentage of founders carrying new alleles (30–60%) and the high average germ line transmission rate (20–30%) also demonstrate that it would be relatively easy to identify founders carrying mutations in genes for which there is no previously characterized mutant phenotype. Taken together, the results suggest that it should be sufficient to screen a handful of embryos from a handful of ZFN-injected founders to identify carriers of new disrupted alleles, if ZFN-induced mutagenesis at kdrl and ntl are an accurate indication of ZFN efficacy at other loci in the zebrafish genome. Because repair by NHEJ creates small deletions and insertions of variable length, it is also possible to create novel alleles of varying strength, nicely demonstrated the isolation of a hypomorphic kdrl allele [12]. Importantly, both groups showed that ZFN-injected fish are fertile and breed normally, suggesting that ZFNs do not create overt deleteri-ous effects.

Unwanted off-target mutations are of concern in any mutagenesis procedure, and reagents like ZFNs that cause DSBs are no exception. Thus, it was critical to assess whether undesired off-target effects might complicate mutation recovery or analysis. To reduce the possibility of unintended mutagenesis at alternative sites within the genome, both studies utilized ZFNs containing obligate heterodimer forms of the Fok1 endonuclease cleavage domain; these modified forms greatly diminish ZFN homodimeric cleavage activity and toxicity by reducing the number of possible off-target sites that are recognized and cleaved [22, 23]. Meng and colleagues [12] used three-finger ZFNs in their study; each ZFN recognizes a 9 bp sequence and together the ZFN pair has an 18 bp recognition sequence interrupted by a 6 bp spacer region (Figure 1A). They identified 41 potential heterodimeric and homodimeric off-target sites in the zebrafish genome, differing by 1–4 bp from the intended target site, and used Solexa sequencing technology to analyse mutagenic activity at these alternative sites. Consistent with the use of obligate heterodimer FokI proteins, they detected no cleavage at homodimeric sites, even in severely deformed embryos. Cleavage at heterodimeric sites was limited to only a few sites and was minimal (~1–5%), with on-target cleavage several 100-fold more likely to occur than off-target cleavage [12]. Doyon and colleagues [11] used four-finger ZFNs in their study; each ZFN pair has a 24 bp recognition sequence interrupted by a 6 bp spacer region (Figure 1B). They identified potential off-target binding sites by experimentally determining a DNA binding consensus for each ZFN, which was then used to search the zebrafish genome for putative alternative sites with highest similarity to the consensus. They sequenced the top five heterodimeric alternative sites from embryos carrying new ntl alleles and detected no off-target lesions [11]. With the caveat that both groups could only analyse for disruption at off-target sites predicted from available genome sequence, and thus would not detect mutations or chromosomal rearrangements elsewhere in the genome, the results suggest that if undesired secondary mutations were to occur, they would rapidly segregate from the desired mutation in subsequent generations.

Both of these highlighted zebrafish studies represent the collaborative effort of researchers who specialize in ZFN design and applications and researchers specializing in zebrafish developmental genetics. Thus, a relevant question for the general research community is how feasible it is for individual laboratories to generate ZFNs that reliably target a gene of interest. Protocols, software and web-based tools are available that describe modular-based approaches to ZFN design [24–26]; although a recent publication summarizing the efficacy of modular-based approaches cautions that modular design approaches have high failure rates unless the design includes fingers with well-validated target sequences [27]. Thus, another critical aspect of the recent zebrafish ZFN work is that both groups describe new assays or approaches that can reliably identify ZFNs that will be active in vivo. Doyon et al. [11] describe a simple yeast-based assay that capitalizes on the fact that yeast cells can utilize single-strand annealing very efficiently to repair DSBs with appropriately designed substrates. In the assay, yeast cells carrying a ‘broken’ MEL1 reporter gene (disrupted with the ZFN target site) driven by a constitutive promoter are transformed with ZFNs predicted to recognize the target site. If the ZFNs efficiently bind and cleave the intended target sequence, the resulting DSB is repaired using single-strand annealing between partial MEL1 sequences carried on the same reporter construct on either side of the ZFN target, restoring the MEL1 reporter open reading frame. Because the yeast MEL1 gene encodes a secreted form of α-galactosidase, the activity of which is easily assayed in culture, restoration of constitutive α-galactosidase reporter activity provides a direct readout of the efficiency of the ZFN pair to bind and cleave the target site in vivo. This yeast assay system may be especially useful for testing ZFNs constructed using modular design strategies. Using a different approach, Meng et al. [12] combined design and selection to build ZFNs with efficient in vivo binding and cleavage activity. Using a bacterial one-hybrid system, they first identified single zinc fingers that efficiently bind to each 3 bp subsite of the 9 bp target sequence. Then, they combined the three independent zinc-finger pool to generate a new three-finger ZFP library, from which candidate zinc-finger proteins were selected based upon how well their DNA binding specificity matched that of the intended target site. Bacterial selection systems are thus also very useful for identifying active ZFNs [12, 28].

The two papers highlighted here demonstrate convincingly that transient ZFN expression, supplied by injection of ZFN-encoding mRNAs into the one-cell embryo, can efficiently create targeted mutations in the zebrafish genome via NHEJ-mediated repair of the resulting DSBs. An exciting implication of the work is that mutations need not be restricted to protein-coding genes, but could be extended to include non-coding sequences such as miRNAs or gene regulatory sequence. The success of ZFN-mediated mutagenesis in zebrafish, which does not require either transgenesis or embryonic stem cells, also suggests that ZFN technology might also be used to generate targeted mutations in the genomes of other model organisms. Finally, the challenge now facing the zebrafish community is to establish conditions that promote ZFN-induced DSB repair by the other major repair pathway, homology-directed repair. Once homologous recombination techniques are established in zebrafish, as they have been in other model systems and in cultured cells [2, 7, 29–31], researchers will be able to precisely control gene modification, allowing one to create of zebrafish models of human disease, engineer conditional alleles, and to knock-in fluorescent protein reporters into endogenous loci, to mention only a few of the myriad of exciting possibilities.

Key Points

  • ZFNs, injected as mRNA into early zebrafish embryos, effectively induce somatic and germline mutations into targeted loci of interest.
  • ZFN-induced mutations are characteristic of NHEJ-mediated DSB repair.
  • ZFN-induced germline mutagenesis is extremely efficient, with 30–60% of ZFN mRNA-injected founders carrying new alleles with an average germ line transmission rate of 20–30%.
  • In the two published reports of ZFN technology applications in zebrafish, unintended mutations at off-target sites within the genome are minimal.
  • Future applications of ZFN technology in zebrafish will likely focus on facilitating ZFN-induced DSB repair using the homology-directed repair pathway.

FUNDING

National Institutes of Health (1-R01-GM061952); March of Dimes (1-FY05-118).

Acknowledgements

I apologize to many researchers in the extensive and rich zinc-finger nuclease field whose work is not referenced in this brief review. I thank Jasmine McCammon and Dr Fyodor Urnov for reviewing the article.

Biography

• 

Sharon Amacher is an Associate Professor in the Department of Molecular and Cell Biology and the Center for Integrative Genomics at the University of California, Berkeley. Her group is applying ZFN technology to study mesodermal patterning of the early vertebrate embryo.

References

  • Capecchi M. Altering the genome by homologous recombination. Science. 1989;244:1288–92. [PubMed]
  • Beumer K, Bhattacharyya G, Bibikova M, et al. Efficient gene targeting in Drosophila with zinc-finger nucleases. Genetics. 2006;172:2391–403. [PubMed]
  • Bibikova M, Golic M, Golic KG, Carroll D. Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics. 2002;161:1169–75. [PubMed]
  • Lloyd A, Plaisier CL, Carroll D, Drews GN. Targeted mutagenesis using zinc-finger nucleases in Arabidopsis. Proc Natl Acad Sci USA. 2005;102:2232–7. [PubMed]
  • Morton J, Davis MW, Jorgensen EM, Carroll D. Induction and repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabditis elegans somatic cells. Proc Natl Acad Sci USA. 2006;103:16370–5. [PubMed]
  • Santiago Y, Chan E, Liu PQ, et al. Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci USA. 2008;105:5809–14. [PubMed]
  • Urnov FD, Miller JC, Lee YL, et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature. 2005;435:646–51. [PubMed]
  • Smith J, Berg JM, Chandrasegaran S. A detailed study of the substrate specificity of a chimeric restriction enzyme. Nucleic Acids Res. 1999;27:674–81. [PMC free article] [PubMed]
  • Bibikova M, Carroll D, Segal DJ, et al. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol. 2001;21:289–97. [PMC free article] [PubMed]
  • Valerie K, Povirk LF. Regulation and mechanisms of mammalian double-strand break repair. Oncogene. 2003;22:5792–812. [PubMed]
  • Doyon Y, McCammon JM, Miller JC, et al. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol. 2008;26:702–8. [PMC free article] [PubMed]
  • Meng X, Noyes MB, Zhu LJ, et al. Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat Biotechnol. 2008;26:695–701. [PMC free article] [PubMed]
  • Camenisch TD, Brilliant MH, Segal DJ. Critical parameters for genome editing using zinc finger nucleases. Mini Rev Med Chem. 2008;8:669–76. [PubMed]
  • Cathomen T, Young JK. Zinc-finger nucleases: the next generation emerges. Mol Therapy. 2008;16:1200–7. [PubMed]
  • Wu J, Kandavelou K, Chandrasegaran S. Custom-designed zinc finger nucleases: what is next? Cell Mol Life Sci. 2007;64:2933–44. [PMC free article] [PubMed]
  • Bussmann J, Lawson N, Zon L, et al. Zebrafish Nomenclature Committee. Zebrafish VEGF receptors: a guideline to nomenclature. PLoS Genet. 2008;4:e1000064. [PMC free article] [PubMed]
  • Covassin LD, Villefranc JA, Kacergis MC, et al. Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish. Proc Natl Acad Sci USA. 2006;103:6554–9. [PubMed]
  • Halpern ME, Ho RK, Walker C, Kimmel CB. Induction of muscle pioneers and floor plate is distinguished by the zebrafish no tail mutation. Cell. 1993;75:99–111. [PubMed]
  • Schulte-Merker S, van Eeden FJM, Halpern ME, et al. no tail (ntl) is the zebrafish homologue of the mouse T (Brachyury) gene. Development. 1994;120:1009–15. [PubMed]
  • Streisinger G, Coale F, Taggart C, et al. Clonal origin of cells in the pigmented retina of the zebrafish eye. Dev Biol. 1989;131:60–9. [PubMed]
  • Lamason RL, Mohideen MA, Mest JR, et al. SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science. 2005;310:1782–6. [PubMed]
  • Miller JC, Holmes MC, Wang J, et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol. 2007;25:778–85. [PubMed]
  • Szczepek M, Brondani V, Büchel J, et al. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol. 2007;25:786–93. [PubMed]
  • Carroll D, Morton JJ, Beumer KJ, Segal DJ. Design, construction and in vitro testing of zinc finger nucleases. Nat Protocols. 2006;1:1329–41. [PubMed]
  • Mandell JG, Barbas CF., III Zinc finger tools: custom DNA-binding domains for transcription factors and nucleases. Nucleic Acids Res. 2006;34(Web Server issue):W516–23. [PMC free article] [PubMed]
  • Sander JD, Zaback P, Joung JK, et al. Zinc finger targeter (ZiFiT): an engineered zinc finger/target site design tool. Nucleic Acids Res. 2007;35:W599–605. [PMC free article] [PubMed]
  • Ramirez CL, Foley JE, Wright DA, et al. Unexpected failure rates for modular assembly of engineered zinc-fingers. Nat Methods. 2008;5:374–5. [PubMed]
  • Pruett-Miller SM, Connelly JP, Maeder ML, et al. Comparison of zinc finger nucleases for use in gene targeting in mammalian cells. Mol Ther. 2008;16:707–17. [PubMed]
  • Bibikova M, Beumer K, Trautman JK, Carroll D. Enhancing gene targeting with zinc finger nucleases. Science. 2003;300:764. [PubMed]
  • Lombardo A, Genovese P, Beausejour CM, et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol. 2007;25:1298–1306. [PubMed]
  • Moehle EA, Rock JM, Lee YL, Jouvenot Y, et al. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA. 2007;104:3055–60. [PubMed]

Articles from Briefings in Functional Genomics and Proteomics are provided here courtesy of Oxford University Press